Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2017

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Shelley Wood

November 22, 2017

Presentation TCT 2017

Take-home Messages and Closing Comments

Presenter: Amal Kumar Banerjee, Rabin dra Nath Chakraborty

October 29, 2017

Presentation TCT 2017

Clinical Case #4: A Complex and High-Risk PCI

Presenter: Anibal A. Damonte, Alejandro O. Palacios, Alejandro Cherro

October 29, 2017

Presentation TCT 2017

STEMI and Cardiogenic Shock With Comorbidities

Presenter: Ayman Abou El Magd, Mohamed Ahmed Sobhy, Mohamed Loutfi

October 29, 2017

Presentation TCT 2017

Case Presentation #2: Complication Made Simple - Managing Longitudinal Stent Distortion

Presenter: Amal Kumar Banerjee, Rabin dra Nath Chakraborty, Saujatya Chakraborty

October 29, 2017

Presentation TCT 2017

What Is the Future of Bioabsorbable Scaffolds?

Presenter: Anibal A. Damonte, Alejandro O. Palacios, Patrick W. Serruys

October 29, 2017

Presentation TCT 2017

Clinical Case #3

Presenter: Anibal A. Damonte, Alejandro O. Palacios, Alfredo E. Rodriguez

October 29, 2017

Presentation TCT 2017

Case Presentation #1: A Complex Left Main PCI Made Simple

Presenter: Amal Kumar Banerjee, Rabin dra Nath Chakraborty, Afzalur Rahman

October 29, 2017

Presentation TCT 2017

CTO Intervention

Presenter: Ayman Abou El Magd, Mohamed Ahmed Sobhy, Sherif ELbeltagui

October 29, 2017

Presentation TCT 2017

Next Generation BRS Platforms

Presenter: Gary S. Mintz, Seung-Jung Park, Alan C. Yeung

October 29, 2017

Presentation TCT 2017

Complex and High-Risk PCI: Who Should Perform These Procedures?

Presenter: Anibal A. Damonte, Alejandro O. Palacios, Qi Zhang

October 29, 2017

Presentation TCT 2017

Heavy Coronary Calcification

Presenter: Ayman Abou El Magd, Mohamed Ahmed Sobhy, Amr Mahmoud Zaki

October 29, 2017

Presentation TCT 2017

BRS Randomized Trials: What Was Wrong the Lesions, the Scaffold, or the Technique?

Presenter: Gary S. Mintz, Seung-Jung Park

October 29, 2017

Presentation TCT 2017

Lessons from the ABSORB Clinical Program for the Future

Presenter: Gary S. Mintz, Seung-Jung Park, Patrick W. Serruys

October 29, 2017

Presentation TCT 2017

UPLMPCI How to Use Evidence and Precision Medicine to Optimize Outcomes, a Case Example

Presenter: Ayman Abou El Magd, Mohamed Ahmed Sobhy, Hany Ragy

October 29, 2017

Presentation TCT 2017

Forty Years After the First PCI, Where Are We and Where Are We Headed?

Presenter: Alejandro Cherro, Alfredo E. Rodriguez, Spencer B. King III

October 29, 2017

News Conference News TCT 2017

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Shelley Wood

October 20, 2017

News Conference News SCCT 2017

Faster, On-site FFRCT May Be on the Horizon Through Innovation and Collaboration

Yael L. Maxwell

July 09, 2017

News Daily News

Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

Todd Neale

February 08, 2017

Advertisement

My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self

Take-home Messages and Closing Comments

Clinical Case #4: A Complex and High-Risk PCI

STEMI and Cardiogenic Shock With Comorbidities

Case Presentation #2: Complication Made Simple - Managing Longitudinal Stent Distortion

What Is the Future of Bioabsorbable Scaffolds?

Clinical Case #3

Case Presentation #1: A Complex Left Main PCI Made Simple

CTO Intervention

Next Generation BRS Platforms

Complex and High-Risk PCI: Who Should Perform These Procedures?

Heavy Coronary Calcification

BRS Randomized Trials: What Was Wrong the Lesions, the Scaffold, or the Technique?

Lessons from the ABSORB Clinical Program for the Future

UPLMPCI How to Use Evidence and Precision Medicine to Optimize Outcomes, a Case Example

Forty Years After the First PCI, Where Are We and Where Are We Headed?

TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More

Faster, On-site FFRCT May Be on the Horizon Through Innovation and Collaboration

Rivaroxaban’s ‘Overwhelming’ Efficacy for Coronary, Peripheral Disease Leads to Early Halt of COMPASS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content